Publication:
Tissue-specific differences in brain phosphodiesters in late-life major depression

dc.contributor.authorHarper, David G.
dc.contributor.authorRavichandran, Caitlin
dc.contributor.authorIosifescu, Dan Vlad
dc.contributor.authorRenshaw, Perry Franklin
dc.contributor.authorForester, Brent P.
dc.contributor.buuauthorSivrioğlu, Yusuf
dc.contributor.buuauthorJensen, J. Eric
dc.contributor.buuauthorSilveri, Marisa M.
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentRuh Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.contributor.scopusid14062563200
dc.contributor.scopusid7404521823
dc.contributor.scopusid7005924854
dc.date.accessioned2022-09-02T11:38:48Z
dc.date.available2022-09-02T11:38:48Z
dc.date.issued2014-05
dc.description.abstractObjective: Late-life depression has been hypothesized to have a neurodegenerative component that leads to impaired executive function and increases in subcortical white matter hyperintensities. Phosphorus magnetic resonance spectroscopy (MRS) can quantify several important phosphorus metabolites in the brain, particularly the anabolic precursors and catabolic metabolites of the constituents of cell membranes, which could be altered by neurodegenerative activity. Methods: Ten patients with late-life major depression who were medication free at time of study and 11 aged normal comparison subjects were studied using P-31 MRS three-dimensional chemical shift imaging at 4 Tesla. Phosphatidylcholine and phosphatidylethanolamine comprise 90% of cell membranes in brain but cannot be quantified precisely with 31P MRS. We measured phosphocholine and phosphoethanolamine, which are anabolic precursors, as well as glycerophosphocholine and glycerophosphoethanolamine, which are catabolic metabolites of phosphatidylcholine and phosphatidylethanolamine. Results: In accordance with our hypotheses, glycerophosphoethanolamine was elevated in white matter of depressed subjects, suggesting enhanced breakdown of cell membranes in these subjects. Glycerophosphocholine did not show any significant difference between comparison and depressed subjects but both showed an enhancement in white matter compared with gray matter. Contrary to our hypotheses, neither phosphocholine nor phosphoethanolamine showed evidence for reduction in late-life depression. Conclusion: These findings support the hypothesis that neurodegenerative processes occur in white matter in patients with late-life depression more than in the normal elderly population.
dc.description.sponsorshipRogers' Family Foundation
dc.description.sponsorshipNARSAD
dc.description.sponsorshipPfizer (K23 MH07728) (R01 MH058681) (R01 DA015116) (R01 AG20654)
dc.description.sponsorshipHarvard Catalyst
dc.description.sponsorshipJohnson & Johnson Johnson & Johnson USA Janssen Biotech Inc
dc.description.sponsorshipEli Lilly
dc.description.sponsorshipOrganon
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute on Aging (NIA)
dc.description.sponsorshipGlaxoSmithKline
dc.description.sponsorshipRoche Holding
dc.description.sponsorshipAspect Medical Systems
dc.description.sponsorshipForest Laboratories
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute of Mental Health (NIMH) (R01MH058681) (K23MH077287)
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute on Aging (NIA) (R01AG020654)
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute on Drug Abuse (NIDA) European Commission (K24DA015116) (K05DA031247)
dc.identifier.citationHarper, D. G. vd. (2014). "Tissue-specific differences in brain phosphodiesters in late-life major depression". American Journal of Geriatric Psychiatry, 22(5), 499-509.
dc.identifier.endpage509
dc.identifier.issn1064-7481
dc.identifier.issn1545-7214
dc.identifier.issue5
dc.identifier.pubmed23567437
dc.identifier.scopus2-s2.0-84901392294
dc.identifier.startpage499
dc.identifier.urihttps://doi.org/10.1016/j.jagp.2012.08.005
dc.identifier.urihttps://www.sciencedirect.com/science/article/abs/pii/S1064748112000322
dc.identifier.urihttp://hdl.handle.net/11452/28440
dc.identifier.volume22
dc.identifier.wos000336087200010
dc.indexed.wosSCIE
dc.indexed.wosSSCI
dc.language.isoen
dc.publisherElsevier
dc.relation.collaborationYurt dışı
dc.relation.collaborationSanayi
dc.relation.journalAmerican Journal of Geriatric Psychiatry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMRSI
dc.subjectP-31 MRS
dc.subjectElderly
dc.subjectAging
dc.subjectMembranes
dc.subjectWhite-matter lesions
dc.subjectPhosphatidylcholine metabolism
dc.subjectExecutive dysfunction
dc.subjectCultured-cells
dc.subjectFrontal-lob
dc.subject4 Tesla
dc.subjectPhosphatidylethanolamine
dc.subjectBiosynthesis
dc.subjectDisease
dc.subjectBurden
dc.subjectGeriatrics & gerontology
dc.subjectPsychiatry
dc.subject.emtreeGlycerophosphoethanolamine
dc.subject.emtreeGlycerophosphorylcholine
dc.subject.emtreePhosphatidylcholine
dc.subject.emtreePhosphatidylethanolamine
dc.subject.emtreePhosphodiesterase
dc.subject.emtreePhosphoethanolamine
dc.subject.emtreePhosphorylcholine
dc.subject.emtreeEthanolamine derivative
dc.subject.emtreeGlycerophosphoethanolamine
dc.subject.emtreeGlycerophosphorylcholine
dc.subject.emtreeOrganophosphorus compound
dc.subject.emtreePhosphatidylethanolamine
dc.subject.emtreePhosphoethanolamine
dc.subject.emtreePhosphorylcholine
dc.subject.emtreeAdult
dc.subject.emtreeAged
dc.subject.emtreeArticle
dc.subject.emtreeCell membrane
dc.subject.emtreeClinical article
dc.subject.emtreeControlled study
dc.subject.emtreeFemale
dc.subject.emtreeGray matter
dc.subject.emtreeHuman
dc.subject.emtreeImage enhancement
dc.subject.emtreeLate life depression
dc.subject.emtreeMajor depression
dc.subject.emtreeMale
dc.subject.emtreePhospholipid membrane
dc.subject.emtreePhospholipid metabolism
dc.subject.emtreePhosphorus nuclear magnetic resonance
dc.subject.emtreeProtein degradation
dc.subject.emtreeProtein synthesis
dc.subject.emtreeProton nuclear magnetic resonance
dc.subject.emtreeQuantitative analysis
dc.subject.emtreeThree dimensional imaging
dc.subject.emtreeTissue specificity
dc.subject.emtreeWhite matter
dc.subject.emtreeAging
dc.subject.emtreeBrain
dc.subject.emtreeCase control study
dc.subject.emtreeMajor depression
dc.subject.emtreeMetabolism
dc.subject.emtreeMiddle aged
dc.subject.emtreeNuclear magnetic resonance spectroscopy
dc.subject.emtreePsychology
dc.subject.emtreeVery elderly
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAging
dc.subject.meshBrain
dc.subject.meshCase-control studies
dc.subject.meshDepressive disorder, major
dc.subject.meshEthanolamines
dc.subject.meshFemale
dc.subject.meshGlycerylphosphorylcholine
dc.subject.meshGray matter
dc.subject.meshHumans
dc.subject.meshMagnetic resonance spectroscopy
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshOrganophosphorus compounds
dc.subject.meshPhosphatidylethanolamines
dc.subject.meshPhosphorylcholine
dc.subject.meshWhite matter
dc.subject.scopusDepression; Cognitive Dysfunction; Dementia
dc.subject.wosGeriatrics & gerontology
dc.subject.wosGerontology
dc.subject.wosPsychiatry
dc.titleTissue-specific differences in brain phosphodiesters in late-life major depression
dc.typeArticle
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Ruh Sağlığı ve Hastalıkları Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: